Last reviewed · How we verify

Beclomethasone dipropionate HFA Nasal Aerosol

Teva Branded Pharmaceutical Products R&D, Inc. · Phase 2 active Small molecule

Beclomethasone dipropionate HFA Nasal Aerosol is a Corticosteroid Small molecule drug developed by Teva Branded Pharmaceutical Products R&D, Inc.. It is currently in Phase 2 development for Allergic rhinitis, Non-allergic rhinitis. Also known as: QNASL(TM).

Beclomethasone dipropionate is a corticosteroid that binds to glucocorticoid receptors, reducing inflammation and immune responses in the nasal passages.

Beclomethasone dipropionate is a corticosteroid that binds to glucocorticoid receptors, reducing inflammation and immune responses in the nasal passages. Used for Allergic rhinitis, Non-allergic rhinitis.

At a glance

Generic nameBeclomethasone dipropionate HFA Nasal Aerosol
Also known asQNASL(TM)
SponsorTeva Branded Pharmaceutical Products R&D, Inc.
Drug classCorticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaRespiratory
PhasePhase 2

Mechanism of action

By binding to glucocorticoid receptors, beclomethasone dipropionate modulates the expression of genes involved in inflammatory and immune responses, leading to a reduction in symptoms associated with nasal inflammation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Beclomethasone dipropionate HFA Nasal Aerosol

What is Beclomethasone dipropionate HFA Nasal Aerosol?

Beclomethasone dipropionate HFA Nasal Aerosol is a Corticosteroid drug developed by Teva Branded Pharmaceutical Products R&D, Inc., indicated for Allergic rhinitis, Non-allergic rhinitis.

How does Beclomethasone dipropionate HFA Nasal Aerosol work?

Beclomethasone dipropionate is a corticosteroid that binds to glucocorticoid receptors, reducing inflammation and immune responses in the nasal passages.

What is Beclomethasone dipropionate HFA Nasal Aerosol used for?

Beclomethasone dipropionate HFA Nasal Aerosol is indicated for Allergic rhinitis, Non-allergic rhinitis.

Who makes Beclomethasone dipropionate HFA Nasal Aerosol?

Beclomethasone dipropionate HFA Nasal Aerosol is developed by Teva Branded Pharmaceutical Products R&D, Inc. (see full Teva Branded Pharmaceutical Products R&D, Inc. pipeline at /company/teva-branded-pharmaceutical-products-r-d-inc).

Is Beclomethasone dipropionate HFA Nasal Aerosol also known as anything else?

Beclomethasone dipropionate HFA Nasal Aerosol is also known as QNASL(TM).

What drug class is Beclomethasone dipropionate HFA Nasal Aerosol in?

Beclomethasone dipropionate HFA Nasal Aerosol belongs to the Corticosteroid class. See all Corticosteroid drugs at /class/corticosteroid.

What development phase is Beclomethasone dipropionate HFA Nasal Aerosol in?

Beclomethasone dipropionate HFA Nasal Aerosol is in Phase 2.

What are the side effects of Beclomethasone dipropionate HFA Nasal Aerosol?

Common side effects of Beclomethasone dipropionate HFA Nasal Aerosol include Nasal discomfort, Epistaxis.

What does Beclomethasone dipropionate HFA Nasal Aerosol target?

Beclomethasone dipropionate HFA Nasal Aerosol targets Glucocorticoid receptor and is a Corticosteroid.

Related